DocDollars

Urogen Pharma, Inc.

NJ · United States · Reporting entity ID 100000776811

Total reported 2019–2025
$15.5M
#381 of 2,960 reporting companies — 0% of all reported industry payments
$8.41M in general payments across 35,882 records, plus $7.14M in research funding across 2,237 records.

How it breaks down

General payments $8,408,178
Research funding $7,135,538

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Urogen Pharma, Inc. reported $15.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #381 of 2,960 reporting companies. 46% of that was research funding and 54% general payments such as consulting, speaking, food and travel. 35,882 general payment records and 2,237 research records were filed.

Common questions about Urogen Pharma, Inc.

How much has Urogen Pharma, Inc. paid US doctors?

Urogen Pharma, Inc. reported $15,543,716 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $8,408,178 in general payments, $7,135,538 in research funding.

How does Urogen Pharma, Inc. rank among drug and device companies?

It ranks #381 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Urogen Pharma, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.